PFIZER ASIA PACIFIC PTE LTD

PFIZER ASIA PACIFIC PTE LTD Company Introduction

Company Type: Neither a factory nor a pure trading company. It functions as the regional headquarters and commercial arm for Pfizer's operations across the Asia Pacific region.

Description:

PFIZER ASIA PACIFIC PTE LTD is the regional hub for Pfizer, Inc., a global pharmaceutical and biotechnology corporation. Located in Singapore, this entity primarily oversees and manages Pfizer's commercial activities, sales, marketing, distribution, and strategic operations throughout the Asia Pacific region. While Pfizer as a global entity manufactures a wide range of pharmaceutical products, PFIZER ASIA PACIFIC PTE LTD itself is not a manufacturing plant or factory. Instead, it serves as a crucial administrative and commercial center, coordinating the delivery of Pfizer's innovative medicines and vaccines to patients across numerous countries in the region. It plays a pivotal role in market access, regulatory affairs, clinical research management, and business development, ensuring the efficient flow of products and information within the complex pharmaceutical landscape of Asia Pacific.

PFIZER ASIA PACIFIC PTE LTD in Singapore is involved in the sale and distribution of a broad portfolio of pharmaceutical products across various therapeutic areas.

These include Vaccines, such as Comirnaty (COVID-19 vaccine) and Prevnar (pneumococcal vaccine).

In Oncology, products include Ibrance (palbociclib) for breast cancer and Xtandi (enzalutamide) for prostate cancer.

For Internal Medicine, they offer medications like Eliquis (apixaban) for anticoagulation and Lipitor (atorvastatin) for cholesterol management.

In Inflammation and Immunology, an example is Xeljanz (tofacitinib) for autoimmune diseases.

Rare Disease treatments include Vyndaqel (tafamidis) for transthyretin amyloidosis.

Anti-infectives such as Zithromax (azithromycin) and Vfend (voriconazole) are also part of their offerings.